Reuters logo
BRIEF-Hubei Biocause Pharma insurance unit's premium income at 37.9 bln yuan in Jan-Aug
September 11, 2017 / 9:46 AM / 3 months ago

BRIEF-Hubei Biocause Pharma insurance unit's premium income at 37.9 bln yuan in Jan-Aug

Sept 11 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd

* Says insurance unit’s premium income at 37.9 billion yuan ($5.81 billion) in Jan-Aug

Source text in Chinese: bit.ly/2fcS258

Further company coverage: ($1 = 6.5211 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below